Home / Health / FDA Approves Groundbreaking Cancer Screening
FDA Approves Groundbreaking Cancer Screening
14 Sep
Summary
- Shield blood test screens for breast, lung, and other cancers.
- The Food and Drug Administration has approved the test.
- New testing methods offer hope for cancer patients.
A significant advancement in cancer detection has been achieved with the FDA's approval of Guardant Health's Shield blood test. This innovative test is designed to screen for multiple types of cancer, including breast, lung, colorectal, ovarian, and pancreatic, in certain adults. The approval marks a critical step forward in cancer screening capabilities.
In discussions with Pamela Brown, Helmy Eltoukhy, CEO of Guardant Health, highlighted the potential of the Shield test. Furthermore, Dr. Lucy De La Cruz, a breast cancer surgeon and oncologist, shared insights into how these new testing methodologies could benefit her patients, emphasizing the promising future for cancer diagnostics and treatment.
